Iran (IMNA) - Neonatal jaundice frequently occurs during the initial days after birth due to the accumulation of the pigment bilirubin. While often benign, elevated bilirubin levels can sometimes indicate serious underlying issues with liver function or the infant’s circulatory system. Accurate diagnosis, categorization of jaundice types, and timely treatment decisions are essential factors in mitigating associated complications.
During the early postnatal period, a newborn’s biological systems gradually adapt from the intrauterine environment to the outside world. The breakdown of older red blood cells during this transition can raise bilirubin levels. Therefore, daily monitoring of bilirubin in newborns is a critical screening measure in medical centers.
Parental involvement after hospital discharge is crucial for ongoing care. Signs such as yellowing of the skin and eyes, lethargy, feeding difficulties, or irritability are warning indicators that should never be ignored. Providing families with proper information and utilizing electronic health records help facilitate swift medical consultations and accurate clinical decisions.
In severe and progressive cases, excessive bilirubin can deposit in brain tissues, a condition known as kernicterus. This can cause irreversible damage affecting motor function, speech, and hearing. Consequently, close monitoring of bilirubin during the neonatal period is of utmost importance.
The Imperative Role of Parents in Recognizing Jaundice Symptoms and Seeking Treatment
Dr. Behzad Barkatin, a pediatrician and neonatologist, emphasized in an interview with IMNA reporters that if neonatal jaundice is pathological, symptoms typically appear before hospital discharge. Newborns usually remain in the hospital 24 to 48 hours after birth to undergo this transitional phase. If jaundice is detected, its cause is identified, and treatment is initiated promptly.
He advised parents to pay special attention during days three to five after birth and consult a physician if symptoms of jaundice emerge. Measuring bilirubin levels and initiating treatment as soon as possible are critical to prevent complications.
Dr. Barkatin also warned against neglect or underestimating jaundice, which can delay diagnosis and treatment. The most significant risk of untreated jaundice is neurological damage to the infant’s brain.
Dr. Barkatin explained that certain brain regions are highly sensitive to elevated bilirubin levels. Deposition of bilirubin in these areas can potentially cause cerebral palsy, motor dysfunction, and hearing impairments in affected infants.
He highlighted the importance of parental awareness and timely medical intervention, noting that with improved healthcare and parental education, such severe outcomes have become rare. However, failure to diagnose and treat jaundice effectively can still jeopardize the newborn’s health.
He also clarified that ordinary fluorescent lights, such as those commonly found at home, are ineffective for treating jaundice. The therapeutic effect requires exposure to light within the wavelength range of 420 to 510 nanometers, typically provided by specialized blue fluorescent lamps. Moreover, inappropriate lighting devices may pose additional risks to the infant.
Phototherapy remains the most common and non-invasive treatment, using specific blue light to convert bilirubin into a form that the body can excrete. Non-standard or household fluorescent lamps are not only ineffective but may endanger the newborn’s health, underscoring the need for standardization of both home and clinical phototherapy equipment.
Recent advancements in medical technology have introduced continuous bilirubin monitoring through skin sensors and smart devices. These innovations reduce the need for frequent blood sampling and enable parents to monitor their infant’s condition in real time, promptly detecting abnormalities.
In summary, effective communication between healthcare teams and families, ongoing training of nurses and physicians, and adoption of cutting-edge technologies can dramatically reduce the incidence of jaundice-related complications. Awareness, prevention, and immediate action constitute the three pillars for successfully managing neonatal jaundice and safeguarding infant health.
Your Comment